Pharmaceutical Development Group, Inc.
Pharmaceutical Development Group (PDG) offers expert FDA regulatory consulting and strategic drug development services. They partner with life sciences companies to navigate complex regulatory pathways, ensuring product safety, efficacy, and commercial success.
Pharmaceutical Development Group (PDG), a subsidiary of Biotech Research Group Corporation, provides comprehensive FDA regulatory consulting and strategic drug development services. With extensive experience dating back to 1999, PDG assists drug and medical device companies in navigating the complexities of the FDA, from early-stage development through post-launch activities. Their expertise spans a wide range of services, including Pre-IND meetings, IND/SPA submissions, clinical trial design, NDA submissions (505(b)(1)/505(b)(2)), and generic drug applications (505(j) ANDAs). PDG also offers specialized consulting for medical devices, covering submissions like 510(k) and PMA, as well as facility inspection readiness and mock audits. PDG's team comprises seasoned professionals, including former FDA regulatory scientists and chemists, who leverage their deep understanding of regulatory requirements to maximize the safety, efficacy, and commercial value of their clients' products. They are dedicated to serving as long-term regulatory partners throughout the product lifecycle, ensuring compliance with cGMP, QSR, and other relevant international standards.
About
**Who they are**
Pharmaceutical Development Group, Inc. (PDG) is a regulatory consulting firm that partners with life sciences companies to navigate complex regulatory pathways, ensuring product safety, efficacy, and commercial success.
**Expertise & scope**
* Expertise in FDA regulations and guidelines, providing insight into current regulatory interpretation.
* Support for FDA interactions through written documents, oral communication, and face-to-face meetings.
* Scientific depth in toxicology, pharmacology, pathology, ADME, and clinical pharmacology.
* Strategic alliance with Advyzom for global regulatory strategy, FDA liaison roles, clinical medical writing, and submissions.
* Scientific and regulatory writing services for submission-ready documents, with quality control reviews.
* Oversight of preclinical studies, with project managers and monitors experienced in contract research organizations (CROs) and regulatory agency requirements.
* Preclinical ADME (absorption, distribution, metabolism, excretion), pharmacology, and pharmacokinetic (PK) strategy and implementation services.
* Clinical pharmacology, pharmacokinetic (PK), and ADME strategy and implementation services.
* GLP (Good Laboratory Practice) report writing for toxicokinetics and pharmacokinetic studies, including data interpretation and QA review.
* Advising on FDA, DMPK (drug metabolism and pharmacokinetics), and pharmacology/toxicology issues for various drug and biologic classes.
**Reputation / proof points**
* Founded in 2026 (based on copyright year on multiple pages, may be inaccurate)
Pharmaceutical Development Group, Inc. (PDG) is a regulatory consulting firm that partners with life sciences companies to navigate complex regulatory pathways, ensuring product safety, efficacy, and commercial success.
**Expertise & scope**
* Expertise in FDA regulations and guidelines, providing insight into current regulatory interpretation.
* Support for FDA interactions through written documents, oral communication, and face-to-face meetings.
* Scientific depth in toxicology, pharmacology, pathology, ADME, and clinical pharmacology.
* Strategic alliance with Advyzom for global regulatory strategy, FDA liaison roles, clinical medical writing, and submissions.
* Scientific and regulatory writing services for submission-ready documents, with quality control reviews.
* Oversight of preclinical studies, with project managers and monitors experienced in contract research organizations (CROs) and regulatory agency requirements.
* Preclinical ADME (absorption, distribution, metabolism, excretion), pharmacology, and pharmacokinetic (PK) strategy and implementation services.
* Clinical pharmacology, pharmacokinetic (PK), and ADME strategy and implementation services.
* GLP (Good Laboratory Practice) report writing for toxicokinetics and pharmacokinetic studies, including data interpretation and QA review.
* Advising on FDA, DMPK (drug metabolism and pharmacokinetics), and pharmacology/toxicology issues for various drug and biologic classes.
**Reputation / proof points**
* Founded in 2026 (based on copyright year on multiple pages, may be inaccurate)
Additional information
Pharmaceutical Development Group, Inc. provides comprehensive support for drug development, from preclinical stages through regulatory submissions. Their services are designed to ensure product safety, efficacy, and market success by leveraging deep scientific expertise and strategic regulatory guidance. They emphasize a collaborative approach, working closely with clients to meet specific project needs and timelines. The firm also highlights its alliance with Advyzom, enhancing its capabilities in global regulatory strategy and FDA liaison roles. Clients can expect detailed oversight of preclinical studies and robust support for regulatory documentation.
Key Highlights
-
Offers expert FDA regulatory consulting and strategic drug development services.
Source
“Pharmaceutical Development Group (PDG) offers expert FDA regulatory consulting and strategic drug development services.”
-
Provides insight into current FDA regulations and guidelines.
Source
“Aclairo consultants are experts in FDA regulations and guidelines and provide insight into current regulatory interpretation at the FDA.”
-
Specializes in scientific depth areas including toxicology, pharmacology, pathology, ADME, and clinical pharmacology.
Source
“Activities are in our areas of scientific depth: toxicology, pharmacology, pathology, ADME, and clinical pharmacology.”
-
Offers GLP report writing for toxicokinetics and pharmacokinetic studies.
Source
“Aclairo now offers GLP report writing for toxicokinetics and pharmacokinetic studies.”
-
Provides strategic advice on FDA, DMPK, and pharmacology/toxicology issues.
Source
“The senior consultants and consultants at Aclairo have extensive experience evaluating and advising on FDA, DMPK, and pharmacology/toxicology issues”
Certifications & Trust Signals
-
Operates under a strategic alliance with Advyzom for enhanced regulatory support.
Source
“We have a strategic alliance with a world-class regulatory group, Advyzom.”
Buyer Snapshot
Best for
- Life sciences companies seeking FDA regulatory consulting.
- Organizations needing strategic drug development guidance.
- Companies requiring support with preclinical studies and regulatory writing.
How engagement typically works
- Partnership approach to navigate regulatory pathways.
- Collaborative support for FDA interactions.
- Detailed oversight and tactical/logistical interface with CROs.
Typical deliverables
- FDA regulatory strategy and guidance.
- Submission-ready regulatory documents.
- Preclinical study oversight and management.
- ADME and pharmacokinetic strategy and implementation.
- GLP TK/PK reports.
Good to know
- Best when clients require specialized expertise in toxicology, pharmacology, ADME, and clinical pharmacology.
HQ:
Sterling, US
Languages:
English
Timezones:
EST
Claim status:
Listed
Services & Capabilities
Best FDA US Agent Services | Compare & Get Quotes
Jurisdictions:
US
Countries:
US
Inspection Support:
Yes
Product Type:
drugs
Additional us_agent_fda Details
Product Types
Drugs and biologics
Registration Support
No
Recall Support
No
Inspection Support
No
Emergency Contact24x7
No
US Entity State
VA
⚡ Instant booking available
Appoint a Vetted FDA U.S. Agent in 2 Minutes
Compare Pharmaceutical Development Group, Inc. and other vetted providers — instant pricing, no RFQ needed.
